trump glp 1 news President Donald announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 weight loss drugs Wegovy and Zepbound, a move that could make them more Lilly, Novo to lower obesity

The global burden of cardiovascular diseases and risk: a compass for future health

3): Novo Nordisk, the patent holder and manufacturer of the GLP-1 products Ozempic, Rybelsus and Wegovy (semaglutide) has spent 41% more on shareholder enrichment (buybacks and dividends) as it has on R&D in the past five years

What compounded semaglutide and tirzepatide actually are Compounded medications are custom-prepared by licensed compounding pharmacies using the same active pharmaceutical ingredients as brand name drugs

Int J Neurosci 133(5):473491

Many gastrointestinal side effects may decrease as treatment continues, but there is no guaranteed week when they disappear

In its statement, the FDA said it is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025. The FDA specifically called out Hims in the announcement